HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
UTP23
UTP23 small subunit processome component
Chromosome 8 · 8q24.11
NCBI Gene: 84294Ensembl: ENSG00000147679.13HGNC: HGNC:28224UniProt: Q9BRU9
38PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
RNA bindingmRNA 3'-UTR bindingprotein bindingmRNA 5'-UTR bindingCornelia de Lange syndromeneurodegenerative diseasecolorectal cancergenetic disorder
✦AI Summary

UTP23 is a nucleolar small subunit processome component essential for ribosome biogenesis and pre-18S rRNA maturation 1. As a core assembly factor, UTP23 coordinates with snoRNPs and ribosomal proteins to facilitate early pre-ribosomal processing events, particularly in central domain formation of the 40S subunit 1. UTP23 functions in rRNA processing and ribosome synthesis through its involvement in the 90S pre-ribosome complex alongside assembly factors like Krr1 and Kri1 1. In cancer pathology, UTP23 represents a significant therapeutic target in pan-cancer ribosome biogenesis programs 2. Elevated UTP23 expression correlates with poor prognosis across multiple cancer types, particularly in luminal A breast cancer and early-stage colorectal cancer 345. In breast cancer, UTP23 promotes cell proliferation, migration, and invasion, possibly through DCAF13 regulation 3. Conversely, in ovarian cancer, UTP23 downregulation associates with paclitaxel chemotherapy resistance via GDF15 upregulation, suggesting UTP23 loss confers drug resistance 6. Notably, cytoplasmic UTP23 localization (rather than nucleolar) drives colorectal cancer metastasis through KRT5 interactions 5. Additionally, UTP23 downregulation impacts pancreatic β-cell survival 7, and coding variants in UTP23 associate with colorectal cancer genetic risk 8.

Sources cited
1
UTP23 functions as an early assembly factor (Utp23) coordinating with snoRNPs and ribosomal proteins in 90S pre-ribosome formation and 18S rRNA subdomain maturation
PMID: 40399280
2
UTP23 identified as one of 128 potential therapeutic targets in pan-cancer ribosome biogenesis programs
PMID: 38343327
3
UTP23 shows high expression in breast cancer, associates with poor overall survival in luminal A breast cancer, and promotes MCF-7 cell proliferation, migration, and invasion via DCAF13 regulation
PMID: 37880005
4
UTP23 is a nucleolar protein essential for ribosome production; high UTP23 expression correlates with poor prognosis in breast cancer and immune cell infiltration
PMID: 38305284
5
Cytoplasmic (non-nucleolar) UTP23 expression promotes colorectal cancer metastasis and invasion; associates with poor prognosis and interacts with KRT5
PMID: 38372088
6
UTP23 downregulation in ovarian cancer promotes paclitaxel chemotherapy resistance through GDF15 upregulation; lower UTP23 correlates with worse patient prognosis
PMID: 31540773
7
UTP23 loss markedly reduces pancreatic β-cell viability in the SLC30A8 locus context
PMID: 38661000
8
Coding variant rs16888728 in UTP23 at 8q24 associates with colorectal cancer risk (OR=1.15, P=1.4×10⁻⁷)
PMID: 26553438
Disease Associationsⓘ20
Cornelia de Lange syndromeOpen Targets
0.53Moderate
neurodegenerative diseaseOpen Targets
0.39Weak
colorectal cancerOpen Targets
0.38Weak
genetic disorderOpen Targets
0.36Weak
Mungan syndromeOpen Targets
0.34Weak
polyp of colonOpen Targets
0.30Weak
benign colon neoplasmOpen Targets
0.30Weak
polyp of large intestineOpen Targets
0.27Weak
colonic neoplasmOpen Targets
0.25Weak
intestinal diseaseOpen Targets
0.24Weak
papillary adenocarcinomaOpen Targets
0.23Weak
colon carcinomaOpen Targets
0.22Weak
benign neoplasmOpen Targets
0.21Weak
stomach polypOpen Targets
0.20Weak
benign neoplasm of rectumOpen Targets
0.20Weak
rectum cancerOpen Targets
0.20Weak
rectal neoplasmOpen Targets
0.18Weak
anal neoplasmOpen Targets
0.18Weak
colon adenocarcinomaOpen Targets
0.17Weak
cecal neoplasmOpen Targets
0.17Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
FCF1Protein interaction100%DDX52Protein interaction100%UTP3Protein interaction100%DDX10Protein interaction100%SNU13Protein interaction100%MPHOSPH10Protein interaction99%
Tissue Expression6 tissues
Bone Marrow
100%
Heart
82%
Ovary
68%
Brain
55%
Liver
52%
Lung
49%
Gene Interaction Network
Click a node to explore
UTP23FCF1DDX52UTP3DDX10SNU13MPHOSPH10
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q9BRU9
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
0.88LoF Tolerant
pLIⓘ
0.01Tolerant
Observed/Expected LoF0.55 [0.35–0.88]
RankingsWhere UTP23 stands among ~20K protein-coding genes
  • #10,572of 20,598
    Most Researched38
  • #7,885of 17,882
    Most Constrained (LOEUF)0.88
Genes detectedUTP23
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Genomic hallmarks and therapeutic targets of ribosome biogenesis in cancer.
PMID: 38343327
Brief Bioinform · 2024
1.00
2
UTP23 Functions in Breast Cancer Progression and Predicts Poor Prognosis of Luminal a Breast Cancer.
PMID: 37880005
Clin Breast Cancer · 2024
0.90
3
H/ACA snR30 snoRNP guides independent 18S rRNA subdomain formation.
PMID: 40399280
Nat Commun · 2025
0.80
4
UTP23 Is a Promising Prognostic Biomarker and Is Associated with Immune Infiltration in Breast Cancer.
PMID: 38305284
Crit Rev Eukaryot Gene Expr · 2024
0.70
5
Down-regulation of UTP23 promotes paclitaxel resistance and predicts poorer prognosis in ovarian cancer.
PMID: 31540773
Pathol Res Pract · 2019
0.60